ANTHONY C HOOPER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANTHONY C HOOPER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANTHONY C HOOPER. ANTHONY C HOOPER is a EVP, Global Commercial Ops. in AMGEN INC ($AMGN) and a President US Pharmaceuticals in BRISTOL MYERS SQUIBB CO ($BMY) and a Director in MANNKIND CORP ($MNKD) and a Director in BeiGene, Ltd. ($BGNE).
Address: BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCELINE ROAD PRINCETON 08540 NJ
Companies in which ANTHONY C HOOPER is an Insider
AMGEN INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ANTHONY C HOOPER: EVP, Global Commercial Ops.
Holdings: 215,147 shares
Current Value: $35,890,823
Latest Transaction: May 07 2018
$AMGN Market Capitalization: $124.07B
$AMGN Previous Close: $166.82
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BeiGene, Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANTHONY C HOOPER: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2020
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BRISTOL MYERS SQUIBB CO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANTHONY C HOOPER: President US Pharmaceuticals
Holdings: 102,331 shares
Current Value: $5,286,419
Latest Transaction: Mar 06 2008
$BMY Market Capitalization: $87.00B
$BMY Previous Close: $51.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MANNKIND CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANTHONY C HOOPER: Director
Holdings: 126,201 shares
Current Value: $64,363
Latest Transaction: May 26 2020
$MNKD Market Capitalization: $244.02M
$MNKD Previous Close: $0.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ANTHONY C HOOPER
Sentiment: All, AMGN, BGNE, BMY, MNKD
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2020 | BGNE | BeiGene, Ltd. | HOOPER ANTHONY C | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| May 26 2020 | MNKD | MANNKIND CORP | HOOPER ANTHONY C | Director | Option Exercise | A | 0.00 | 38,760 | 0 | 38,760 | |
| May 26 2020 | MNKD | MANNKIND CORP | HOOPER ANTHONY C | Director | Option Exercise | A | 0.00 | 88,235 | 0 | 88,235 | |
| Mar 06 2020 | BGNE | BeiGene, Ltd. | HOOPER ANTHONY C | Director | Option Exercise | A | 12.22 | 21,970 | 268,473 | 21,970 | |
| Mar 04 2020 | MNKD | MANNKIND CORP | HOOPER ANTHONY C | Director | Grant | A | 0.00 | 30,048 | 0 | 126,201 | 96.2 K to 126.2 K (+31.25 %) |
| May 07 2018 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Payment of Exercise | F | 169.43 | 883 | 149,607 | 215,147 | 216 K to 215.1 K (-0.41 %) |
| May 01 2018 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Option Exercise | A | 177.46 | 34,702 | 6,158,217 | 34,702 |